Recall Register

Food, drugs, devices › Fujifilm Medical Systems U.S.A., Inc.

Device recall: Fujifilm FDR Go PLUS, Mobile X-Ray System Product Usage: This device is intended to be used to take a film, CR or genera

FDA enforcement event 82187 · Class II · initiated 15 Jan 2019 · status Terminated · terminated 8 Oct 2020

DeviceVoluntary: Firm initiated1 product recordLexington, MA

FDA enforcement event 82187 is a device recall by Fujifilm Medical Systems U.S.A., Inc. of Lexington, MA, initiated 15 Jan 2019 and classified Class II, with 1 product record.

FDA defines Class II as a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote. 88% of the 968 device enforcement events initiated in 2019 carry the same class.

Status: Terminated, terminated 8 Oct 2020. Initiation: voluntary: firm initiated. Fujifilm Medical Systems U.S.A., Inc. has 27 enforcement events on this register, with a median of 1 product record per event.

Recall classification reflects the relative degree of health hazard. Text in quotation marks is FDA's. openFDA export dated 28 Sep 2026.

Recalling firm

Fujifilm Medical Systems U.S.A., Inc., Lexington, MA.

Reason for recall

"FUJIFILM Medical Systems U.S.A., Inc., Modality Systems became aware of the possibility that the braking mechanism might not be engaged in all cases when the driving handle has been released."

Distribution

"US Nationwide Distribution"

Product records

Recall numberProductQuantityClassStatusReport date
Z-1040-2019Fujifilm FDR Go PLUS, Mobile X-Ray System Product Usage: This device is intended to be used to take a film, CR or general radiography of patients in the hospital who cannot move and/or of outpatients in emergency. Exposure can be captured on film, CR or Digital Radiography (DR)>56 unitsClass IITerminated27 Mar 2019

Context

88%of 2019 device events are Class II968 events that year
1product record in this eventfirm median: 1
27events on this register for the firm

Other enforcement events for Fujifilm Medical Systems U.S.A., Inc.

InitiatedProduct (first record)TypeClassRecords
30 Apr 2021Synapse Cardiovascular (Synapse CV). Software Versions: 6.0 to 6.2.1 The Synapse Cardiovascular image is a management anDeviceClass II1
2 Mar 2021Synapse PACS - Radiological Image Processing System - Product Usage: intended for use, as a web based application, on anDeviceClass II1
18 Feb 2021¿TASWako Chip Cassette is part of the Wako ¿TASWako i30 kitDeviceClass II1
22 Dec 2020Wako HDL-C/LDL-C Calibrator - Product Usage: designed to be used with Wako L-Type HDL-C or L-Type LDL-C for the determinDeviceClass III1
11 Dec 2020FUJIFILM Synapse PACS Software: versions 7.0.0 and 7.0.1 - Product Usage: intended for use as a web based application onDeviceClass II1
11 Sep 2020Synapse PACS Software Versions 5.1 and higherDeviceClass II1
11 Sep 2020Synapse PACS Software Version 5.6.1 - Product Usage: intended for use as a web based application on an off-the shelf PC DeviceClass II1
22 May 2020Fujifilm Synapse PACS Software Version 5.5.x and 5.7.x- intended as interface to the FUJIFILM Synapse PACS Software (SerDeviceClass II1
19 Jul 2019Fujifilm FDR Go Plus mobile X-ray systemDeviceClass II1
4 Aug 2017Aspire HD (for FDR-1000AWS) The Fujifilm Digital Mammography System, Aspire HD (FDR MS-l000), generates full-field digitDeviceClass II4

All 27 events for Fujifilm Medical Systems U.S.A., Inc.

Questions and answers

Why was this device recalled?

FDA's record gives the reason for recall as: "FUJIFILM Medical Systems U.S.A., Inc., Modality Systems became aware of the possibility that the braking mechanism might not be engaged in all cases when the driving handle has been released."

What does Class II mean?

FDA classifies recalls by relative degree of health hazard. Class II is a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote.

Where was the product distributed?

FDA's distribution pattern field reads: "US Nationwide Distribution"

Is the recall still ongoing?

FDA lists the status as Terminated; the termination date is 8 Oct 2020. "Terminated" means FDA has determined that all reasonable efforts to remove or correct the product have been made.

Where does this data come from?

openFDA enforcement reports (food, drug and device), CC0, export dated 28 Sep 2026. Text in quotation marks is FDA's. The FDA enforcement report linked above is authoritative.

Provenance

Source: openFDA device enforcement reports (CC0), export dated 28 Sep 2026; records grouped by FDA event number. The class shown for the event is the most severe class among its records. Errors in processing are corrected at the next build; see corrections.